Zalmox-TM
MOXIFLOXACIN
- A fourth-generation, 8-methoxy fluoroquinolone with bactericidal activity
- Disrupts bacterial replication by inhibiting enzymes like DNA gyrase (topoisomerase II) and topoisomerase IV
- Shows superior activity compared with ciprofloxacin against quinolone-resistant strains of S. aureus
TOBRAMYCIN
- An aminoglycoside antibiotic with a broad antibacterial spectrum
- Acts by binding to the 30S and 50S ribosomal subunits, thereby disrupting bacterial protein synthesis
- Significantly more effective than gentamicin sulphate against the 4 combined conjunctival pathogens
INDICATIONS
- Bacterial Conjunctivitis
- Post-Operative and Post-Lasik Prevention From Vision-Threatening Bacterial Infections
